Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Sinclair

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Immunotherapy|November 15, 2021
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summaryThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.
The New England Journal of Medicine|March 24, 2021
Abrocitinib versus Placebo or Dupilumab for Atopic DermatitisThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.
The Australasian Journal of Dermatology|September 30, 2025
Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus StatementDaniella Kushnir-Grinbaum, Laita Bokhari, John Frewen, et al.
International Journal of Dermatology|February 16, 2026
Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel RecommendationsRodney Sinclair, Chao-Chun Yang, Wen-Hung Chung, et al.
Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001Elise A Olsen, Wilma F Bergfeld, George Cotsarelis, et al.
The Australasian Journal of Dermatology|August 6, 2025
Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus ExerciseMeryl Thomas, Madeline Hankins, Emadodin Darchini-Maragheh, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Dermatologic Clinics|September 24, 2021
Dermatology COVID-19 Registries: Updates and Future DirectionsEsther E Freeman, Grace C Chamberlin, Devon E McMahon, et al.
The New England Journal of Medicine|October 3, 2019
Ligelizumab for Chronic Spontaneous UrticariaMarcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Immunotherapy|November 15, 2021
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summaryThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.
The New England Journal of Medicine|March 24, 2021
Abrocitinib versus Placebo or Dupilumab for Atopic DermatitisThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.
The Australasian Journal of Dermatology|September 30, 2025
Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus StatementDaniella Kushnir-Grinbaum, Laita Bokhari, John Frewen, et al.
International Journal of Dermatology|February 16, 2026
Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel RecommendationsRodney Sinclair, Chao-Chun Yang, Wen-Hung Chung, et al.
Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001Elise A Olsen, Wilma F Bergfeld, George Cotsarelis, et al.
The Australasian Journal of Dermatology|August 6, 2025
Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus ExerciseMeryl Thomas, Madeline Hankins, Emadodin Darchini-Maragheh, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Dermatologic Clinics|September 24, 2021
Dermatology COVID-19 Registries: Updates and Future DirectionsEsther E Freeman, Grace C Chamberlin, Devon E McMahon, et al.
The New England Journal of Medicine|October 3, 2019
Ligelizumab for Chronic Spontaneous UrticariaMarcus Maurer, Ana M Giménez-Arnau, Gordon Sussman, et al.
Pageof 26